BRPI0318840B8 - complexo de carboidrato de ferro (iii) hidrossolúvel e uso do mesmo - Google Patents

complexo de carboidrato de ferro (iii) hidrossolúvel e uso do mesmo

Info

Publication number
BRPI0318840B8
BRPI0318840B8 BRPI0318840A BR0318840A BRPI0318840B8 BR PI0318840 B8 BRPI0318840 B8 BR PI0318840B8 BR PI0318840 A BRPI0318840 A BR PI0318840A BR 0318840 A BR0318840 A BR 0318840A BR PI0318840 B8 BRPI0318840 B8 BR PI0318840B8
Authority
BR
Brazil
Prior art keywords
iii
water
aqueous solution
soluble iron
carbohydrate complex
Prior art date
Application number
BRPI0318840A
Other languages
English (en)
Portuguese (pt)
Other versions
BRPI0318840B1 (pt
Inventor
Philipp Erik
Geisser Peter
Richle Walter
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32102937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0318840(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of BRPI0318840B1 publication Critical patent/BRPI0318840B1/pt
Publication of BRPI0318840B8 publication Critical patent/BRPI0318840B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
BRPI0318840A 2002-10-23 2003-10-20 complexo de carboidrato de ferro (iii) hidrossolúvel e uso do mesmo BRPI0318840B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10249552A DE10249552A1 (de) 2002-10-23 2002-10-23 Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
DE10249552.1 2002-10-23
PCT/EP2003/011596 WO2004037865A1 (de) 2002-10-23 2003-10-20 Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
BRPI0315452A BRPI0315452B8 (pt) 2002-10-23 2003-10-20 complexo de carboidrato de ferro hidrossolúvel, sua produção, seu uso e medicamentos contendo os mesmos”

Publications (2)

Publication Number Publication Date
BRPI0318840B1 BRPI0318840B1 (pt) 2021-02-02
BRPI0318840B8 true BRPI0318840B8 (pt) 2021-05-25

Family

ID=32102937

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0315452A BRPI0315452B8 (pt) 2002-10-23 2003-10-20 complexo de carboidrato de ferro hidrossolúvel, sua produção, seu uso e medicamentos contendo os mesmos”
BRPI0318840A BRPI0318840B8 (pt) 2002-10-23 2003-10-20 complexo de carboidrato de ferro (iii) hidrossolúvel e uso do mesmo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0315452A BRPI0315452B8 (pt) 2002-10-23 2003-10-20 complexo de carboidrato de ferro hidrossolúvel, sua produção, seu uso e medicamentos contendo os mesmos”

Country Status (29)

Country Link
US (11) US7612109B2 (enExample)
EP (2) EP1554315B1 (enExample)
JP (2) JP4777653B2 (enExample)
KR (1) KR100992178B1 (enExample)
CN (1) CN100480275C (enExample)
AR (1) AR041472A1 (enExample)
AT (1) ATE507246T1 (enExample)
AU (1) AU2003278111C1 (enExample)
BR (2) BRPI0315452B8 (enExample)
CA (1) CA2493806C (enExample)
CY (2) CY1112680T1 (enExample)
DE (2) DE10249552A1 (enExample)
DK (2) DK2287204T3 (enExample)
ES (2) ES2385788T3 (enExample)
IL (1) IL166747A (enExample)
JO (3) JO3286B1 (enExample)
MX (1) MXPA05004300A (enExample)
MY (1) MY134394A (enExample)
NO (2) NO333008B1 (enExample)
NZ (1) NZ539243A (enExample)
PE (1) PE20040571A1 (enExample)
PT (2) PT1554315E (enExample)
RU (1) RU2303039C2 (enExample)
SA (1) SA03240447B1 (enExample)
SI (2) SI2287204T1 (enExample)
TW (1) TWI265028B (enExample)
UY (1) UY28033A1 (enExample)
WO (1) WO2004037865A1 (enExample)
ZA (1) ZA200504174B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6757848B2 (en) 2001-06-19 2004-06-29 Hewlett-Packard Development Company, L.P. Recovery of user data from partially incorrect data set in tape data storage system
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
DK1848446T3 (da) * 2005-02-09 2010-02-15 Vifor Int Ag anvendelse af jern(III)-kompleksforbindelser
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
KR101514470B1 (ko) * 2007-02-06 2015-04-22 메디칼 리서취 카운실 리간드 개질 폴리 옥소-히드록시 금속 이온 물질, 이의 용도 및 이의 제조 방법
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
JP5426010B2 (ja) 2009-03-25 2014-02-26 ファーマコスモス ホールディング エー／エス 安定な鉄オリゴ糖化合物
US20120214986A1 (en) * 2009-11-04 2012-08-23 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
PH12012501814A1 (en) 2010-03-23 2012-12-10 Vifor Int Ag Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US9370202B2 (en) 2013-03-15 2016-06-21 LG Bionano, LLC Encapsulated metal ion nanoclusters
US9384629B2 (en) 2014-03-31 2016-07-05 Fresh Idea Global Limited Automated money laundering detection, notification, and reporting techniques implemented at casino gaming networks
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
EP2997968A1 (en) 2014-09-22 2016-03-23 Ioulia Tseti Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same
CN104402984B (zh) * 2014-11-11 2018-09-07 武汉科福新药有限责任公司 一种高载铁量的蛋白琥珀酸铁的制备方法
CN107438626A (zh) * 2015-03-23 2017-12-05 苏文生命科学有限公司 水溶性三价铁碳水化合物复合物的制备
WO2016181195A1 (en) 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
US20180147234A1 (en) * 2015-05-29 2018-05-31 Luitpold Pharmaceuticals, Inc. Compositions and methods for treatment of fibromyalgia
CN105125577B (zh) * 2015-07-29 2018-05-18 南京生命能科技开发有限公司 一种稳定的糖-铁复合物及其制备方法
CN105125578B (zh) * 2015-07-29 2018-05-11 南京生命能科技开发有限公司 一种具有高溶解速度的糖-铁复合物及其制备方法
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
CN105520955B (zh) * 2015-12-21 2018-05-11 南京生命能科技开发有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
CN108129582A (zh) * 2016-12-01 2018-06-08 江苏奥赛康药业股份有限公司 一种铁碳水化合物复合物的制备方法
EP3339329A1 (en) 2016-12-22 2018-06-27 LEK Pharmaceuticals d.d. Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes
EP4559468A3 (en) 2017-09-11 2025-06-25 Pharmacosmos Holding A/s Iron complex compounds for therapeutic use
WO2019193608A1 (en) * 2018-04-05 2019-10-10 Msn Laboratories Private Limited, R&D Center Improved process for the preparation of iron (iii) carboxymaltose
CN108498539A (zh) * 2018-05-03 2018-09-07 东营天东制药有限公司 一种水溶性铁剂复合体原料药的制备方法
EP3873492A1 (en) 2018-10-29 2021-09-08 Pharmacosmos Holding A/s Treating iron deficiency with ferric carboxymaltose
EP3897661A1 (en) 2018-12-21 2021-10-27 Vifor (International) Ag Ferric carboxymaltose in the treatment of heart failure and in the treatment of congestion in heart failure
CN110218267B (zh) * 2019-07-04 2020-08-07 汉邦环宇多糖生物科技（河源）有限公司 一种右旋糖酐铁的制备方法及用途
US11447513B2 (en) * 2020-02-12 2022-09-20 Rk Pharma Inc. Purification process of ferric carboxymaltose
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CA3191492A1 (en) * 2020-09-29 2022-04-07 LG Bionano, LLC Methods of preparing iron complexes
TWI784646B (zh) 2021-07-29 2022-11-21 台耀化學股份有限公司 製備羧基麥芽糖鐵的方法
JP2024534172A (ja) 2021-08-27 2024-09-18 ヴァイフォー（インターナショナル）アーゲー 鉄組成物並びにそれらを作製及び使用する方法
WO2023041957A1 (en) * 2021-09-16 2023-03-23 Virchow Biotech Private Limited Efficient process for the synthesis of iron (iii) carbohydrate complexes
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE370194C (de) 1923-02-28 Therese Rocksch Geb Laschet Elektrolytisches Zinnbad zur Darstellung schwammfreier Zinnkristalle
CA623411A (en) 1961-07-04 Muller Arthur Process for the manufacture of iron-polyisomaltose complex for therapeutical purposes
US1129307A (en) * 1914-12-26 1915-02-23 Howard L Marsh Process of forming compounds of iron and carbohydrates.
GB199951A (en) 1922-07-07 1923-07-05 William Swann Improvements in or relating to clamps or fastening devices for the brake chains of perambulators, and the like
DE461370C (de) 1925-06-13 1928-06-21 Chem Fab Vormals Sandoz Verfahren zur Herstellung von Monocarbonsaeuren aus Aldosen
GB289280A (en) 1927-06-17 1928-04-26 Chem Fab Vormals Sandoz Process for the oxidation of aldoses
GB335965A (en) 1929-06-05 1930-10-06 Ig Farbenindustrie Ag Process for the manufacture of complex iron compounds
US2807610A (en) 1952-02-15 1957-09-24 Baker Chem Co J T Hydrogenated dextran
GB748024A (en) 1953-02-27 1956-04-18 Benger S Ltd Improved therapeutic preparations of iron
GB828404A (en) * 1958-05-07 1960-02-17 Chugai Pharmaceutical Co Ltd A process for preparing divalent or trivalent metallic salts of glucuronic acid
GB879441A (en) 1959-05-25 1961-10-11 Crookes Lab Ltd Improved injectable iron preparations
US3065138A (en) 1959-10-09 1962-11-20 Warren Teed Products Company Therapeutic preparations of elemental iron
GB928238A (en) 1960-01-14 1963-06-12 Diamond Lab Inc Methods of preparing therapeutic preparations of iron
US3100202A (en) 1960-06-17 1963-08-06 Muller Arthur Process for preparing an iron hydroxide polyisomaltose complex and the resulting product
US3086009A (en) * 1960-07-19 1963-04-16 Diamond Lab Inc Process for preparing a water soluble hydrolyzed starch-ferric iron complex
GB978485A (en) 1960-10-26 1964-12-23 Astra Apotekarnes Kem Fab Iron preparations for intramuscular injection
GB928236A (en) 1960-11-22 1963-06-12 Atomic Energy Authority Uk Improvements in or relating to organic liquid moderated and cooled nuclear reactors
US3151107A (en) 1960-12-22 1964-09-29 Central Pharmacal Company Water-soluble iron complexes of carboxymethyl dextran
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
GB985206A (en) 1961-12-20 1965-03-03 Hausmann Ag Labor Improvements in or relating to therapeutic iron preparation
ES282099A1 (es) 1962-11-02 1963-01-01 Rocador Sa Procedimiento para la preparación de un complejo de óxido de hierro y ácidos dextránicos
BE652508A (enExample) * 1963-08-30
FR1451203A (fr) 1964-01-31 1966-01-07 Rocador Sa Procédé pour la fabrication d'un complexe d'oxyde ferrique et de polysaccharide
DE1617463A1 (de) 1965-11-20 1971-04-08 Bayer Ag Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
SE322866B (enExample) * 1966-12-15 1970-04-20 Astra Ab
GB1200902A (en) * 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
GB1199951A (en) 1967-05-13 1970-07-22 Fisons Pharmaceuticals Ltd Modified Dextran and Derivatives Thereof
US3395229A (en) 1967-07-03 1968-07-30 Mattox And Moore Inc Process and product for combatting iron deficiency anemia in suckling pigs
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
GB1258566A (enExample) 1968-07-12 1971-12-30
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
SE359447B (enExample) 1971-10-06 1973-09-03 Astra Laekemedel Ab
US3928581A (en) 1972-09-13 1975-12-23 Astra Laekemedel Ab Certain polymer-iron complexes for treatment of iron deficiency
US3969395A (en) 1972-10-04 1976-07-13 Astra Lakemedel Aktiebolag Polymers of hydroxy carboxylic acid and a polyhydric alcohol
US3965133A (en) 1972-10-04 1976-06-22 Astra Lakemedel Aktiebolag Polymer
US4056672A (en) 1973-03-22 1977-11-01 Astra Lakemedel Aktiebolag Polymer prepared by cyanhydrin method
JPS6039681B2 (ja) 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
US4370476A (en) 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4335116A (en) 1980-10-07 1982-06-15 University Patents, Inc. Mineral-containing therapeutic compositions
DE51707T1 (de) 1980-11-12 1983-04-14 Izu West Hill Ontario Hattori Dextranpolycarboxylierte saeuren, ihre komplexe mit ferrihydroxyd, sie enthaltende arzneimittel und verfahren zu deren herstellung.
DE3114699A1 (de) 1981-04-10 1982-10-28 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zum messen der roentgenroehrenhochspannung
HU187167B (en) 1982-10-15 1985-11-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical solution of new type polynuclear iron/iii/ mixed complex activity
CS245379B1 (cs) 1983-12-12 1986-09-18 Karel Capek Způsob výroby komplexů sacharózy s biogenními prvky
US4788281A (en) 1984-01-04 1988-11-29 Tosoni Anthony L Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof
US5746999A (en) * 1984-11-23 1998-05-05 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
DE3443251C2 (de) * 1984-11-23 1998-03-12 Schering Ag Eisenoxid-Komplexe für die NMR-Diagnostik, diese Verbindungen enthaltende diagnostische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
US4640837A (en) 1985-10-15 1987-02-03 General Foods Corporation Coating composition for microwave cooking
US5160726A (en) * 1990-02-15 1992-11-03 Advanced Magnetics Inc. Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
US5102652A (en) 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
KR880012235A (ko) 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법
CN1038753C (zh) * 1988-10-14 1998-06-17 广西化工研究所 葡聚糖铁的制备方法
GB8902894D0 (en) 1989-02-09 1989-03-30 Fisons Plc Compositions
JP2726520B2 (ja) 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体
ATE124960T1 (de) 1989-11-10 1995-07-15 Tno Verfahren zur herstellung von polydicarboxysacchariden.
US5424419A (en) 1991-06-11 1995-06-13 Meito Sangyo Kabushiki Kaisha Oxidized complex comprising water-soluble carboxypolysaccharide and magnetic iron oxide
TW293036B (enExample) 1992-11-27 1996-12-11 Takeda Pharm Industry Co Ltd
EP0634174A1 (en) 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use
NL194919C (nl) 1993-09-07 2003-07-04 Tno Werkwijze voor het oxideren van koolhydraten.
FR2720398B1 (fr) * 1994-05-26 1996-07-05 Commissariat Energie Atomique Complexes de métaux trivalents avec un polyol tel que le cis-inositol, utilisables à des fins médicales et leur procédé de préparation.
GB9514090D0 (en) * 1995-07-11 1995-09-13 Cerestar Holding Bv Non-catalysed oxidation of maltodextrin with an oxygen containing oxidant
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
ES2195023T3 (es) 1995-11-09 2003-12-01 Abbott Lab Procedimiento de preparacion de hierro-dextrano cristalino.
FR2742755B1 (fr) * 1995-12-21 1998-02-20 Roquette Freres Procede perfectionne d'oxydation des sucres
US5756715A (en) 1996-11-08 1998-05-26 Abbott Laboratories Process for making crystalline iron dextran
CA2195283C (en) 1997-01-16 2008-07-22 Thomas C. Usher Process for manufacturing iron dextran using ultrafiltration
IT1291289B1 (it) 1997-04-30 1999-01-07 Derivati Organici Lab Complessi costituiti da fe(iii) un composto poliidrossilato e ovalbumina
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DE19833548A1 (de) 1998-07-25 2000-02-03 Messer Griesheim Gmbh Überkritische Fluorierung
US6587550B2 (en) 1998-09-02 2003-07-01 Michael O. Council Method and apparatus for enabling a fee to be charged to a party initiating an electronic mail communication when the party is not on an authorization list associated with the party to whom the communication is directed
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DE60043188D1 (de) 1999-04-09 2009-12-03 Amag Pharmaceuticals Inc Hitzebeständige umhüllte kolloidale eisenoxide
US6703499B1 (en) 1999-04-29 2004-03-09 Polydex Pharmaceuticals Ltd. Process of making carboxylated dextran
US6495177B1 (en) 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
US6521247B1 (en) 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
US20020119174A1 (en) 2000-07-26 2002-08-29 Gardlik John Michael Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
EP1719496A3 (en) 2000-11-02 2007-05-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
US6929954B2 (en) * 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
AU2002246556B2 (en) * 2000-11-02 2006-06-01 Chromaceutical Advanced Technologies, Inc Method for producing purified hematinic iron-saccharidic complex and product produced
CN1353194A (zh) * 2000-11-02 2002-06-12 杨敏 生产20%右旋糖酐铁的方法
RU2003121403A (ru) 2000-12-07 2004-12-27 АД "ЗДРАВЛЬЕ" Фармасеутско-кемийска индустри , Сентар за истразиванье и развой (YU) Полиядерный комплекс fe(iii) с олигомерами пуллулана, способ его получения и фармацевтические препараты на его основе
JP2002260951A (ja) 2000-12-28 2002-09-13 Denso Corp 積層型誘電素子及びその製造方法，並びに電極用ペースト材料
BR0308773A (pt) 2002-04-09 2005-02-09 Pharmacosmos Holding As Compostos de dextrina de ferro para tratamento de anemia por deficiência de ferro
EA200500062A1 (ru) 2002-06-21 2005-06-30 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема
ES2315401T3 (es) * 2002-08-26 2009-04-01 Vifor (International) Ag Prueba de bioequivalencia para formulaciones que contienen hierro.
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
KR20060108692A (ko) 2003-10-31 2006-10-18 알자 코포레이션 메트포르민의 개선된 흡수를 위한 조성물 및 제형
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
DK1848446T3 (da) 2005-02-09 2010-02-15 Vifor Int Ag anvendelse af jern(III)-kompleksforbindelser
US7815621B2 (en) * 2005-07-07 2010-10-19 Eisai R & D Management Co. Ltd. Recovery system
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
US7660481B2 (en) 2005-11-17 2010-02-09 Vital Images, Inc. Image enhancement using anisotropic noise filtering
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
PT1973549T (pt) * 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
US8778878B2 (en) 2007-01-29 2014-07-15 Chyna, LLC Use of ferritin to treat iron disorders
US8071542B2 (en) 2007-01-29 2011-12-06 Chyna, LLC Use of ferritin to treat iron deficiency disorders
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20120214986A1 (en) 2009-11-04 2012-08-23 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
BRPI0904979A2 (pt) 2009-12-04 2011-07-19 Braskem Sa processo para produção de olefinas, olefina, poliolefina, e, uso da poliolefina
US9120838B2 (en) 2011-04-18 2015-09-01 Curators Of The University Of Missouri Saccharide conjugates
US8772101B2 (en) 2012-11-08 2014-07-08 Globalfoundries Inc. Methods of forming replacement gate structures on semiconductor devices and the resulting device
CN107438626A (zh) 2015-03-23 2017-12-05 苏文生命科学有限公司 水溶性三价铁碳水化合物复合物的制备
WO2016181195A1 (en) 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
EP3339329A1 (en) 2016-12-22 2018-06-27 LEK Pharmaceuticals d.d. Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes

Also Published As

Publication number Publication date
NO333008B1 (no) 2013-02-18
AR041472A1 (es) 2005-05-18
US11291645B2 (en) 2022-04-05
US9376505B2 (en) 2016-06-28
EP2287204A1 (de) 2011-02-23
KR20050070014A (ko) 2005-07-05
PE20040571A1 (es) 2004-10-01
AU2003278111A1 (en) 2004-05-13
EP1554315B1 (de) 2011-04-27
DK1554315T3 (da) 2011-07-04
CA2493806C (en) 2014-02-11
SA03240447B1 (ar) 2008-09-14
US20210115163A1 (en) 2021-04-22
TWI265028B (en) 2006-11-01
US11123321B2 (en) 2021-09-21
UY28033A1 (es) 2004-06-30
BRPI0318840B1 (pt) 2021-02-02
SI1554315T1 (sl) 2011-09-30
JOP20180046A1 (ar) 2019-01-30
JP4777653B2 (ja) 2011-09-21
NO20110654L (no) 2005-07-18
JP2006505638A (ja) 2006-02-16
KR100992178B1 (ko) 2010-11-05
CN1705682A (zh) 2005-12-07
JO3286B1 (ar) 2018-09-16
CY1113387T1 (el) 2016-06-22
IL166747A0 (en) 2006-01-15
US20160215071A1 (en) 2016-07-28
AU2003278111C1 (en) 2010-12-02
DE50313653D1 (de) 2011-06-09
BRPI0315452B8 (pt) 2021-05-25
RU2303039C2 (ru) 2007-07-20
NO20052410L (no) 2005-07-18
CN100480275C (zh) 2009-04-22
JP5289413B2 (ja) 2013-09-11
IL166747A (en) 2010-11-30
PT2287204E (pt) 2012-07-18
CA2493806A1 (en) 2004-05-06
NO20052410D0 (no) 2005-05-13
US20120316133A1 (en) 2012-12-13
US20190276563A1 (en) 2019-09-12
MXPA05004300A (es) 2005-11-23
US20130203698A1 (en) 2013-08-08
BR0315452A (pt) 2005-08-23
US20060205691A1 (en) 2006-09-14
EP1554315A1 (de) 2005-07-20
DE10249552A1 (de) 2004-05-13
TW200420289A (en) 2004-10-16
ZA200504174B (en) 2006-04-26
NZ539243A (en) 2007-05-31
PT1554315E (pt) 2011-06-30
ATE507246T1 (de) 2011-05-15
JOP20110173B1 (ar) 2021-08-17
JP2011052226A (ja) 2011-03-17
HK1081976A1 (zh) 2006-05-26
CY1112680T1 (el) 2016-02-10
HK1149574A1 (en) 2011-10-07
US20140371169A1 (en) 2014-12-18
ES2364136T3 (es) 2011-08-25
US20220387371A1 (en) 2022-12-08
WO2004037865A1 (de) 2004-05-06
MY134394A (en) 2007-12-31
US20100099647A1 (en) 2010-04-22
DK2287204T3 (da) 2012-07-23
US20210054105A1 (en) 2021-02-25
SI2287204T1 (sl) 2012-09-28
AU2003278111B8 (en) 2009-06-04
US20190263939A1 (en) 2019-08-29
NO335770B1 (no) 2015-02-09
US10519252B2 (en) 2019-12-31
RU2005115455A (ru) 2005-12-10
AU2003278111B2 (en) 2009-05-28
ES2385788T3 (es) 2012-07-31
JOP20180046B1 (ar) 2022-09-15
US11590097B2 (en) 2023-02-28
US7612109B2 (en) 2009-11-03
BRPI0315452B1 (pt) 2015-12-01
EP2287204B1 (de) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI0318840B8 (pt) complexo de carboidrato de ferro (iii) hidrossolúvel e uso do mesmo
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
WO2003038028A3 (de) Im wesentlichen sedimentfrei dispergierbares wasch- oder reinigungsmittel
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
KR880004844A (ko) 유기 과산화물 수성분산액
CO5180582A1 (es) Soluciones farmaceuticas de levosimendan
BR0113489A (pt) Embalagens solúveis em água contendo composições lìquidas
EP0831056A3 (en) Hydrogen peroxide complexes of inorganic salts and synthesis thereof
KR960034384A (ko) 곰팡이 제거제 조성물
HUP0400520A2 (hu) Klindamicint és cinksót tartalmazó dermatológiai készítmények
HRP20100027T1 (hr) Upotreba kompleksnih spojeva željeza (iii)
CA2361929A1 (en) Liquid deodorant
YU174090A (sh) Penušavi preparati
BRPI0403909A (pt) Solução aquosa de tensoativos anfotéricos altamente concentrada
CA2051892A1 (en) Hydrophobically modified carboxyalkyl hydroxyalkyl ethers of polygalactomannans
HRP20031004B1 (hr) Postupak za proizvodnju stabilne vodene otopine klor kisika u biti bez klorita, otopina klor kisika dobivena tim postupkom kao i njihova primjena
PL438390A1 (pl) Środek dezynfekujący o przedłużonej trwałości działania
DE50208361D1 (de) Reinigungs- und desinfektionsmittel
KR870009637A (ko) 살균제 조성물
BR9901790A (pt) Concentrado de substância ativa
DK1369122T3 (da) Anticancermiddel
DE59808046D1 (de) Brausezubereitung enthaltend ein Pflanzenextrakt
KR920009689A (ko) 안정화 이산화염소 수용액의 제조방법
WO2000046328A3 (de) Verwendung von phosphonsäure-modifizierten polyacrylaten als sequestriermittel
AR043901A1 (es) Una composicion detergente

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 6O DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF